These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 9066679

  • 1. Expression of proteins correlated with the unique cisplatin-sensitivity of testicular cancer.
    de Graaf TW, de Jong S, de Vries EG, Mulder NH.
    Anticancer Res; 1997; 17(1A):369-75. PubMed ID: 9066679
    [Abstract] [Full Text] [Related]

  • 2. Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines.
    Yamada M, Tomida A, Yoshikawa H, Taketani Y, Tsuruo T.
    Clin Cancer Res; 1996 Feb; 2(2):427-32. PubMed ID: 9816187
    [Abstract] [Full Text] [Related]

  • 3. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
    Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ.
    Cancer Res; 2003 Jan 15; 63(2):513-21. PubMed ID: 12543810
    [Abstract] [Full Text] [Related]

  • 4. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S, Mese H, Sasaki A, Yoshioka N, Matsumura T.
    Cancer Chemother Pharmacol; 2003 Jun 15; 51(6):505-11. PubMed ID: 12709826
    [Abstract] [Full Text] [Related]

  • 5. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.
    Liu LZ, Zhou XD, Qian G, Shi X, Fang J, Jiang BH.
    Cancer Res; 2007 Jul 01; 67(13):6325-32. PubMed ID: 17616691
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sequential X-irradiation induced acquired resistance to oxaliplatin but increased sensitivity to cisplatin in two human teratoma cell lines in vitro.
    Eisenmann S, Voigt W, Müller T, Dempke W.
    Anticancer Res; 2010 Nov 01; 30(11):4471-6. PubMed ID: 21115895
    [Abstract] [Full Text] [Related]

  • 8. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
    Nishi M, Abe Y, Fujimori S, Hamamoto A, Inoue Y, Miyazaki N, Oida Y, Ikoma N, Ohnishi Y, Yamazaki H, Ueyama Y, Nakamura M.
    Oncol Rep; 2005 Aug 01; 14(2):421-4. PubMed ID: 16012725
    [Abstract] [Full Text] [Related]

  • 9. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K, Oshima T, Kobayashi T, Yamamoto N, Hayashi C, Matsumoto T, Miwa H.
    Anticancer Res; 2008 Aug 01; 28(4B):2087-92. PubMed ID: 18751380
    [Abstract] [Full Text] [Related]

  • 10. Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10.
    Le Moguen K, Lincet H, Deslandes E, Hubert-Roux M, Lange C, Poulain L, Gauduchon P, Baudin B.
    Proteomics; 2006 Oct 01; 6(19):5183-92. PubMed ID: 16941573
    [Abstract] [Full Text] [Related]

  • 11. Inherent sensitivity and induced resistance to chemotherapeutic drugs and irradiation in human cancer cell lines: relationship to mutation frequencies.
    Parris CN, Walker MC, Masters JR, Arlett CF.
    Cancer Res; 1990 Dec 01; 50(23):7513-8. PubMed ID: 2253200
    [Abstract] [Full Text] [Related]

  • 12. Possible mechanism responsible for the acquisition of resistance to cis-diamminedichloroplatinum (II) by cultured human testicular seminoma cells.
    Kobayashi T, Fujii T, Jo Y, Kinugawa K, Fujisawa M.
    J Urol; 2004 May 01; 171(5):1929-33. PubMed ID: 15076314
    [Abstract] [Full Text] [Related]

  • 13. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
    Matsuhashi N, Saio M, Matsuo A, Sugiyama Y, Saji S.
    Oncol Rep; 2005 Sep 01; 14(3):609-15. PubMed ID: 16077963
    [Abstract] [Full Text] [Related]

  • 14. A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment.
    Le Moguen K, Lincet H, Marcelo P, Lemoisson E, Heutte N, Duval M, Poulain L, Vinh J, Gauduchon P, Baudin B.
    Proteomics; 2007 Nov 01; 7(22):4090-101. PubMed ID: 17994630
    [Abstract] [Full Text] [Related]

  • 15. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
    Spierings DC, de Vries EG, Vellenga E, de Jong S.
    Cell Death Differ; 2003 Jul 01; 10(7):808-22. PubMed ID: 12815464
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line.
    Mese H, Sasaki A, Nakayama S, Yokoyama S, Sawada S, Ishikawa T, Matsumura T.
    Anticancer Res; 2001 Jul 01; 21(2A):1029-33. PubMed ID: 11396136
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.